Michelle O’Donoghue, MD, MPH, is an Associate Physician in the Cardiology Division of Brigham and Women’s Hospital, an Affiliate Physician in the Cardiology Division of Massachusetts General Hospital and an Assistant Professor in Medicine at Harvard Medical School in Boston, Massachusetts. She is an investigator in the Thrombolysis in Myocardial Infarction (TIMI) Study Group, founded by Dr. Eugene Braunwald.
Dr. O’Donoghue’s primary research focus is the design and conduct of multicenter clinical trials for patients with stable and unstable heart disease. Additional clinical research interests include the evaluation of novel antiplatelet drugs, established and novel biomarkers, the study of women and heart disease and the development of novel therapeutics in the management of acute coronary syndromes.
Dr. O’Donoghue is widely published in journals including the Journal of the American Medical Association, The Lancet, Circulation, Journal of the American College of Cardiology, European Heart Journal and Archives of Internal Medicine. Her contributions include original research, editorials, reviews and book chapters. She has been distinguished twice by the American Heart Association, earning both the Laennec Young Clinician Award and the Women in Cardiology Trainee Award for Excellence. She has received awards from the American Medical Women’s Association and American College of Cardiology. She was also honored with the Desanctis Clinical Scholars Award at Massachusetts General Hospital.
Dr. O’Donoghue earned her medical degree from Columbia University College of Physicians and Surgeons in New York. She completed her residency in internal medicine and fellowship in cardiovascular medicine at Massachusetts General Hospital in Boston. She subsequently completed a Masters in Public Health degree at the Harvard School of Public Health.